[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=434746072ca27c7a6f57b725d5a90608387e71aaa36b5079e88ddc2edcf244c5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755276360,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 136391204,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=434746072ca27c7a6f57b725d5a90608387e71aaa36b5079e88ddc2edcf244c5"
    }
  },
  {
    "ts": null,
    "headline": "Can Eylea HD and Dupixent Profits Revive Regeneron Stock?",
    "summary": "REGN banks on Dupixent and Eylea HD gains to offset Eylea's decline while oncology wins strengthen its diversified pipeline.",
    "url": "https://finnhub.io/api/news?id=7be23d3b0273412f452c53e52c4ac3144ffc1c445092e1ccff547b5b0122ade0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755267000,
      "headline": "Can Eylea HD and Dupixent Profits Revive Regeneron Stock?",
      "id": 136370270,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "REGN banks on Dupixent and Eylea HD gains to offset Eylea's decline while oncology wins strengthen its diversified pipeline.",
      "url": "https://finnhub.io/api/news?id=7be23d3b0273412f452c53e52c4ac3144ffc1c445092e1ccff547b5b0122ade0"
    }
  },
  {
    "ts": null,
    "headline": "Intellia Therapeutics: It May Be Time To Get Excited And Buy (Upgrade)",
    "summary": "Intellia Therapeutics, Inc.'s gene-editing therapies show strong potential with robust efficacy, safety, and market demand. Click for my NTLA earnings update.",
    "url": "https://finnhub.io/api/news?id=759b1eabf2cf8bbfd97f848c7f433566054302a346e6a178f4f10845d392ad1e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755260645,
      "headline": "Intellia Therapeutics: It May Be Time To Get Excited And Buy (Upgrade)",
      "id": 136370325,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1399018368/image_1399018368.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Intellia Therapeutics, Inc.'s gene-editing therapies show strong potential with robust efficacy, safety, and market demand. Click for my NTLA earnings update.",
      "url": "https://finnhub.io/api/news?id=759b1eabf2cf8bbfd97f848c7f433566054302a346e6a178f4f10845d392ad1e"
    }
  },
  {
    "ts": null,
    "headline": "Financial Services Roundup: Market Talk",
    "summary": "Find insight on Scion Asset Management, Hong Leong Bank and more in the latest Market Talks covering Financial Services.",
    "url": "https://finnhub.io/api/news?id=d672141fc14927fa729db221826673846350fba2cee1a7433c5025be18c048f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755252060,
      "headline": "Financial Services Roundup: Market Talk",
      "id": 136368362,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Find insight on Scion Asset Management, Hong Leong Bank and more in the latest Market Talks covering Financial Services.",
      "url": "https://finnhub.io/api/news?id=d672141fc14927fa729db221826673846350fba2cee1a7433c5025be18c048f1"
    }
  }
]